Search

everythinglearnresearchcommunity

for

Search:↓

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Some Korean herb extracts can reduce inflammation and are safe for skin use.

Enhancing immune response can improve cancer treatment effectiveness.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

The skin plays a key role in immune responses and reflects emotional and stress reactions.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.